Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases

Author:

Wang Chiuhui Mary,Whiting Amy Heagle,Rath Ana,Anido Roberta,Ardigò Diego,Baynam Gareth,Dawkins Hugh,Hamosh Ada,Le Cam Yann,Malherbe Helen,Molster Caron M.,Monaco Lucia,Padilla Carmencita D.,Pariser Anne R.,Robinson Peter N.,Rodwell Charlotte,Schaefer Franz,Weber Stefanie,Macchia Flaminia

Abstract

AbstractImproving health and social equity for persons living with a rare disease (PLWRD) is increasingly recognized as a global policy priority. However, there is currently no international alignment on how to define and describe rare diseases. A global reference is needed to establish a mutual understanding to inform a wide range of stakeholders for actions. A multi-stakeholder, global panel of rare disease experts, came together and developed an Operational Description of Rare Diseases. This reference describes which diseases are considered rare, how many persons are affected and why the rare disease population demands specific attention. The operational description of rare diseases is framed in two parts: a core definition of rare diseases, complemented by a descriptive framework of rare diseases. The core definition includes parameters that permit the identification of which diseases are considered rare, and how many persons are affected. The descriptive framework elaborates on the impact and burden of rare diseases on patients, their caregivers and families, healthcare systems, and society overall. The Operational Description of Rare Diseases establishes a common point of reference for decision-makers across the world who strive to understand and address the unmet needs of persons living with a rare disease. Adoption of this reference is essential to improving the visibility of rare conditions in health systems across the world. Greater recognition of the burden of rare diseases will motivate new actions and policies to address the unmet needs of the rare disease community.

Publisher

Springer Science and Business Media LLC

Reference33 articles.

1. UN General Assembly (74th sess. 2019–2020) High-Level Plenary Meeting on Universal Health. Political Declaration of the High-Level Plenary Meeting on Universal Health Coverage: resolution / adopted by the General Assembly, A/RES/74/2.

2. UN General Assembly (76th sess. 2021–2022). Addressing the challenges of persons living with a rare disease and their families: resolution / adopted by the General Assembly, A/RES/76/132.

3. Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77–8.

4. Chan AYL, Chan VKY, Olsson S, Fan M, Jit M, Gong M, et al. Access and Unmet needs of Orphan drugs in 194 countries and 6 areas: A Global Policy Review with Content Analysis. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2020;23(12):1580–91.

5. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165–73.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3